Harrisvaccines is an innovative animal vaccine producer based in Ames, Iowa. Because Harrisvaccines utilizes state-of-the-art RNA technology not widely recognized in the industry, they have a strong need to educate industry stakeholders, media, and consumers about the safety and efficacy of their products. Harrisvaccines employed LS2group’s assistance for public and media relations efforts aimed at increasing overall brand awareness and garnering support for the brand.
LS2group worked to increase brand awareness and exposure for Harrisvaccines by connecting with and educating key members of the traditional print, broadcast, and agricultural media and by identifying and activating industry validators. LS2group solidified key messaging that truly conveys the important work Harrisvaccines does, promote the crucial need for their unique technology, and define how their technology changes the industry standard.
Identifying, forming, and strengthening relationships with key members of the media (local, regional, national, trade, and international) has allowed LS2group to create positive brand awareness for Harrisvaccines and has established key members of the Harrisvaccines team as industry experts. Throughout this relationship, LS2group was able to utilize the media relationships formed to get interviews and stories with dozens of outlets, including The Wall Street Journal, The New York Times, Bloomberg, The Des Moines Register, Agri-Pulse, and more. Through award nominations, LS2group was also able to boost the presence of Harrisvaccines at the local, regional, and national levels – pursuing and winning awards such as: Technology Association of Iowa’s Prometheus Awards, a spot on Inc. 5000’s list of America’s Fastest-Growing Private Companies, and Ernst & Young’s Entrepreneur of the Year Award for the Upper Midwest.